Stay updated with breaking news from Kylie Okeefe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Review of European marketing application for PKU now initiated - WARREN, N.J., May 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. announced today that the sepiapterin MAA for PKU has been...
- European Commission decides against adoption of negative opinion - - Translarna authorization remains active in Europe - - 2024 revenue guidance paused - WARREN, N.J., May 20, 2024 /PRNewswire/ --...
- European Commission decides against adoption of negative opinion -- Translarna authorization remains active in Europe -- 2024 revenue guidance paused - WARREN, N.J., May 20, 2024 /PRNewswire/
PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc.
- First marketing authorization submission for sepiapterin with additional global submissions to follow in 2024 - SOUTH PLAINFIELD, N.J., March 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. ...